The medical history and perioperative course of all infants who underwent SA over a 28-month period were collected (retrospectively in the first 20).
Results: Sixty-two infants underwent surgery under SA. Fifty-five were premature and former-premature, postconceptional age 43.3 ± 5.0 weeks, weight 3261 ± 1243 g. Of these, 21 had co-existing disease: cerebral (six), cardiac (nine), pulmonary (11) and urological (six). Hyperbaric tetracaine or bupivacaine 1 mg·kg -1 with adrenaline was administered. Four infants (three premature) required N 2 O supplementation and three needed general anesthesia. The supplementation rate was similar or lower than in previous studies. Postoperatively, all seven were shown to have lower limb motor and sensory blockade. Complications in premature patients included intraoperative hypoxemia (two), apnea (two) and bradycardia (one). Postoperative complications included bradycardia (three), hypoxemia (one) and apnea and hypoxemia (one). The postoperative complication rate was similar to previous studies.
Conclusion: Successful SA in infants depends on close attention to preoperative assessment, appropriate patient positioning during and after lumbar puncture, drug dosing and intra-and postoperative cardiorespiratory monitoring. A relatively high dose of hyperbaric solution of tetracaine or bupivacaine with adrenaline should be administered. REMATURE infants' survival has increased in recent years and due to co-morbidity more infants may require anesthesia and surgery. 1 Inguinal hernia is diagnosed in 9-30% of premature infants 2, 3 with incarceration occurring in up to 31% of patients. 2, 4, 5 However, incarceration and its potential complications 2, 5, 6 may be prevented by early surgical repair.
Objectif : Montrer les aspects techniques et les pièges de la rachianesthésie (RA) chez les enfants.

Méthode : Nous avons noté les antécédents médicaux et le déroule-ment périopératoire pour tous les enfants qui ont eu une RA au cours de 28 mois (de façon rétrospective pour les 20 premiers).
Résultats
Traditionally, surgical repair was performed under general anesthesia. However, general anesthesia increases the risk of 'postoperative apnea' (breath-holding, hypoxemia, bradycardia, or their combinations) in up to 80% of premature and former-premature infants. 1, [7] [8] [9] [10] [11] The risk of anesthetic-induced 'postoperative apnea' diminishes markedly between 44 and 60 weeks postconceptional age, 1, 7, 11, 12 but persists longer in older anemic infants. 7 Spinal anesthesia (SA) may reduce the risk of any of the three components of 'postoperative apnea' in this high-risk group. 8, 10 Its use in premature and other infants has increased considerably since Abajian et al. drew attention to this technique over 15 years ago. 1 3 However, technical aspects of the technique and intraoperative complications attributed to SA are rarely mentioned.
We present our experience of SA in premature, former-premature and full-term young infants over a 28-month period. Emphasis is placed on the technical aspects and intraoperative complications associated with SA in this population.
Patients and methods
The medical history and perioperative course of all children who underwent SA at our institution over a 28-month period were collected. Data of the first 20 patients were reviewed retrospectively. Gestational and postconceptional age, birth and current weight, coexisting disease, hematocrit, and perioperative course were recorded.
Preoperative preparation
Contra-indications for SA included coagulopathy, local [site of lumbar puncture (LP)] or systemic infection, meningitis, intracranial bleeding, intracranial hypertension, hydrocephalus, presence of a cerebrospinal fluid (CSF) draining device, hypovolemia and spinal deformities.
Diet was unrestricted until six hours preoperatively. Clear fluids were encouraged until three hours before induction. A maintenance iv glucose and electrolyte solution was infused from the start of preoperative fasting in in-patients prior to induction until resumption of enteral feeding after surgery. Patients admitted from home also received iv Hartmann's solution except for those with chronic lung disease. 1 4 Ninety minutes prior to surgery, 0.5-1 mL of EMLA® cream (Astra Sodertalje, Sweden), was applied to the midline area over L 4 -S 1 and covered with an occlusive dressing (Tegaderm, 3 M Health Care, St. Paul, MN, USA).
To prevent leakage of the cream, parents and staff were instructed to avoid placing the infant supine. All patients were unpremedicated.
Anesthetic technique
Operating room temperature was maintained between 27-30°C. Monitoring included a pulse oximeter, electrocardiogram, non-invasive blood pressure monitor and precordial stethoscope. One to 2 mL of 50% glucose were given per os prior to iv line insertion or SA induction. An operating theatre team member seated the infant 15, 16 on a folded towel 10 cm above the operating table (Figure 1 ). Gauze was placed between the buttocks to prevent perineal spillage of the antiseptic solutions. A 100% oxygen mask was placed near the patient's face. To avoid pain on removal, the occlusive EMLA® dressing was removed using a Convacare adhesive remover wipe (ConvaTec, Princeton, NJ, USA.) and the sterile field was prepared.
A 2.5-cm, 25-gauge Quincke spinal needle 1 5 (Beckton Dickinson, Franklin Lakes, NJ, USA) was inserted in the midline, cephalad, in an interspace between L 4 and S 1 ( Figure 2 ). This approach was adopted to avoid potential damage to the conus medullaris which terminates at L 3 in infants. 13, 15 Subarachnoid placement, was confirmed by free flow of CSF. With the needle stabilized, the local anesthetic solution was rapidly injected without aspiration 13, 17 and the needle removed. All patients received 1 mg·kg -1 of either 0.5% hyperbaric tetracaine (a 1:1 mixture of 1% tetracaine and 10% glucose) or 0.5% hyperbaric bupivacaine with adrenaline 1:1000 added to either medication. 1 5 Patients treated with diuretics received 0.8 mg·kg -1 of local anesthetic to compensate for a potential contraction of CSF volume. The adrenaline was first drawn up in a 1-mL syringe with detachable needle. Excess adrenaline was expelled from the syringe hub, leaving 20-40 µg in the syringe. The local anesthetic solution was then added into the 1-mL syringe. The patient was immediately positioned supine with a 20-30° head up tilt for two to three minutes, and then horizontally.
Successful SA was defined as lack of sensation to pinch at the desired sensory level and paralysis of the lower limbs. These signs, as well as defecation and diaphragmatic breathing with reduced intercostal muscle activity usually developed within one to three minutes of injection. A paracetamol suppository (20-25 mg·kg -1 ) was inserted pr before the beginning of surgery, or 10-15 mg·kg -1 of paracetamol syrup was given per os postoperatively. 1 8 With hands restrained to avoid interference with the surgical procedure, the patient received a dummy dipped in glucose water. If the patient showed signs of unsatisfactory block, N 2 O was supplemented via a face mask. If this did not suffice, general anesthesia was induced with sevoflurane and N 2 O in oxygen via a face mask and the trachea was intubated. Anesthesia was maintained with isoflurane and N 2 O in oxygen. At the end of the procedure, an ilioinguinal and iliohypogastric nerve block was performed with plain bupivacaine, to a maximum dose of 2 mg·kg -1 at a volume of 0.75-1.5 mL at each incision site.
The patients of the premature group were transferred to the neonatal intensive care unit (NICU) and were monitored for 'postoperative apnea' by pulse oximeter, electrocardiogram and impedance pneumography, all with alarm activation, using the Horizon 1100 (Mennen, Rehovot, Israel) and Hewlett Packard M1106 (Germany) monitors. Postoperatively, apnea is defined at our NICU as cessation of breathing for 20 sec or longer, 1 9 hypoxemia by SpO 2 lower than 92%, and bradycardia below 90 beats·min -1 . Infants who were 'apnea-free' for 12-24 hr were 'stepped down' to a lower level area of monitoring. Full-term infants were routinely monitored in the recovery room and thereafter in the pediatric surgical ward.
Results
Sixty-five infants originally presented for surgery. The subarachnoid space could not be identified in three premature infants and they were excluded from the present study. Fifty-five premature and former-premature (premature group), and seven full-term infants were operated on under SA (Table I) .
Twenty-one of the premature infants (38%) had coexisting disease (Table II) . Fifty-three of the infants in the premature group underwent inguinal hernia repair (17 unilateral, two with orchidopexy) and two underwent pyloromyotomy. Of the seven full-term infants, five underwent inguinal hernia repair. Of these, two infants underwent urgent surgery shortly after having bronchiolitis. One with an active upper respiratory infection was operated on urgently and one infant underwent SA following parental request. One fullterm infant suspected of having nemaline myopathy underwent gastrostomy and muscle biopsy and an additional infant with a provisional diagnosis of mucopolysaccharidosis underwent pyloromyotomy.
An iv line was inserted prior to anesthetic induction in all infants except one in whom several iv cannulation attempts before induction of SA had failed. Cannulation was performed in the lower limb after SA induction in one patient. In 13 cases blood emerged through the spinal needle. SA was performed successfully in 49 of the 55 premature (89%) and six of the seven full-term infants (86%). Three premature infants (5.4%) received supplemental N 2 O, with prompt relief of discomfort. All three had pre-and postoperative lower limb motor and sensory blockade. The infant who underwent gastrostomy showed signs of discomfort when the bowel was replaced into the abdomen prior to wound closure. Bupivacaine infiltration into the surgical wound and brief administration of 70% N 2 O in oxygen via face mask relieved the discomfort. Three of the premature group (5.4%) required general anesthesia. In one of these despite an initial sensory level of T 3 , severe technical problems with operating room equipment resulted in the need for general anesthesia 44 min after the beginning of pyloromyotomy. Failure of the SA in the other two premature patients occurred despite free flow of CSF through the spinal needle. However, postoperative sensory and motor blockade of the lower limbs (complete in one and incomplete in another), were observed postoperatively.
Intraoperative respiratory complications occurred in five infants. In two infants breath-holding episodes occurred within two to three minutes of injection and lasted one to two minutes (Table III) . The patients were immediately placed in reverse-Trendelenburg position and bag and mask ventilation with 100% oxygen initiated until the resumption of spontaneous breathing. SpO 2 below 90% was observed in two additional patients (one premature). Normal SpO 2 was reestablished with 100% oxygen bag and mask assisted ventilation in one infant, and returned spontaneously to normal in the other. A fifth patient developed bradycardia without apnea or hypoxemia 13 min after induction that was resistant to tactile stimulation but responded to iv atropine. In all other infants, SpO 2 was 95% (one patient) or higher, and heart rate was 107 or higher. Postoperative apnea was diagnosed in five of the premature group (9.1%). Hypoxemia (one infant) and apnea and hypoxemia (one infant) occurred upon arrival to NICU. Of the three premature infants who developed bradycardia, one had received iv opioids several hours previously. Hypoxemia was noted in one full-term infant at the end of pyloromyotomy when the sensory level was at T 5 and resolved with supplemental oxygen. None of the infants who received N 2 O supplementation experienced postoperative apnea. One premature infant with no previous history of wheezing developed a postoperative expiratory wheeze after a successful SA and was treated with inhaled bronchodilators.
Discussion
The objectives of SA in premature and former-premature infants are analgesia and muscle relaxation with minimal physiological disturbance, rapid recovery and prevention of complications associated with prematurity or its treatment. 1 7 The risk of 'postoperative apnea' is lower with SA than with general anesthesia 8,10,17 as long as sedatives or general anesthetics are not administered. 8, 17 SA is therefore the anesthetic of choice at our institution in premature and former-premature infants for short abdominal surgical procedures and hence, for ethical reasons, we did not design a comparative study. All our premature patients had two out of the three risk factors associated with 'postoperative apnea': low gestational (under 37 weeks) 7 and postconceptional age (under 60 weeks). 1, 7, 11 The third risk factor, anemia 7, 9 or borderline hematocrit was present in about 50% (Table I) . Five full-term infants with co-existing disease underwent SA in order to avoid potential risks of general anesthesia. 20, 21 Our technique is to sit the patient for LP, flex the lumbar spine, hips and knees, partially extend the neck and support the head. 1 5 The sitting patient is less mobile, 16 bony landmarks are more prominent and the CSF hydrostatic pressure increases, thus allowing faster detection of CSF. 1 5 Head flexion may lead to hypoventilation. 15 Furthermore, sitting the patient may reduce the fall in PO 2 usually seen during LP. 1 6 We advise sitting the patient above the level of the operating table on folded towels. If the patient is seated directly on the table, the needle hub may be too close to the table making syringe attachment difficult. Alternatively, the syringe may be connected to the needle via an extension tube filled with the anesthetic solution, or when CSF appears the patient may be leaned forward to allow syringe attachment (Navil F Sethna, MD, Children's Hospital, Boston, USA, personal communication). A styletted needle should be used to prevent the rare complication of intraspinal epidermoid tumour due to seeding of epidermal cells. 1 5 We use 2.5 or 5-cm 25-gauge spinal needles, but other diameters may be used. 8, 13, 15, 17 We do not try to aspirate CSF through the spinal needle as this can lead to needle displacement from the subarachnoid space. Contrary to others, we do not delay needle removal, a practice advocated to prevent fluid loss in the track. 1 7 Nevertheless, our practice is associated with at least the same success 
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rate of SA reported by others. 10, 22 In 13 cases blood emerged through the spinal needle. Based on our experience, we advise not to withdraw the needle since CSF may still appear. CSF appearance may be accelerated by absorption of the blood from the needle hub by gauze rolled into a cone. If this does not happen, the needle should be withdrawn slowly until CSF appears or until the needle is completely withdrawn and another LP is attempted.
Immediately after subarachnoid injection the patient is placed in a 20-30° reverse-Trendelenburg position for two to three minutes to prevent a higher than desirable motor block. However, if this position is maintained longer, the sensory level may be inadequate.
Higher doses of local anesthetics per kilogram body weight (1 mg·kg -1 ) are required in infants compared with adults and may be related to the larger volume of distribution (CSF) (4 vs 2 mL·kg -1 in adults) or to the relatively increased surface area of the spinal cord and nerve roots. 15, 17 While lower doses may result in a low sensory level or patchy anesthesia, 10, 15, 17, 22 higher doses usually cause loss of lower intercostal muscle activity as evidenced by reduction of chest wall expansion and paradoxical breathing. 23 There is an increased reliance on the diaphragm for tidal breathing 1 5 as evidenced by increased abdominal excursion. 2 3 While 1 mg·kg -1 of tetracaine or bupivacaine usually results in a sensory level of T 2 -T 4 , 1 5 higher levels may be observed. 2 4 The motor level is usually two to three segments lower than the sensory level. 15, 23 Despite the high anesthetic level, hemodynamic and respiratory stability are maintained. 15, [22] [23] [24] This is explained by less dependence on vasomotor tone in newborns 1 5 and a compensatory decrease in vagal activity. 2 4 Caudal anesthesia may also be administered to premature infants. We prefer, however, the use of SA because of its faster onset, the profound sensory blockade and flaccid paralysis, the smaller local anesthetic dose requirements and CSF flow confirming correct needle placement. The disadvantages of SA compared with caudal anesthesia include its shorter duration, greater technical difficulties and the impossibility to use a catheter to prolong anesthetic duration.
Almost 90% of our patients had satisfactory SA with no need for anesthetic or analgesic supplementation, compared with 79% 2 2 and 67% 1 0 in previous reports. Our higher success rate may be related to a higher dose of local anesthetic (1 vs 0.5 2 2 and 0.6 1 0 mg·kg -1 ).
The much shorter duration of SA in neonates compared to adults may be related to the higher volume of distribution and increased cardiac output. This results in faster drug distribution, uptake and elimination of the drug. 13, 15, 17 Motor level regression is approximately five times faster than in adults. Adding epinephrine to tetracaine increases the block duration by an average of 32%. 1 3 After the onset of SA, infants who are restless during the LP become quiet and some fall asleep. 17 Intraoperative complications attributed to SA in infants are uncommon and usually are not reported. Apnea, hypoxemia or bradycardia may be related to prematurity, pain during LP or hypoventilation due to a 'high spinal'. 2 3 'High spinal' occurs in 3-25% of infants, 17, 22, 25 and bradycardia or hypoxemia in 2.3%. 2 2 In our series, despite the presence of co-existing disease in 38% of our patients, intraoperative complications were few and treated easily (Table III) . We speculate that the episode of apnea that occurred in a patient on diuretic therapy, may be the result of a contracted CSF volume, decreasing the volume of distribution of the local anesthetic and increasing the level of anesthesia. The anesthetic dose may be reduced to 0.8 mg·kg -1 in patients who receive diuretics (Navil F Sethna, MD, Children's Hospital, Boston, USA, personal communication).
We have no explanation for the hypoxemia at the end of pyloromyotomy in a full-term infant with a block to level T 5 . Hypoventilation secondary to the metabolic alkalosis of pyloric stenosis may have been a contributory factor.
The most common postoperative complication is 'postoperative apnea'. It results from the combination of prematurity, anesthetic agent exposure 1 , 8 and increased endogenous opioid production in the first 72 hr postoperatively. 1 Its three components (breath-holding, hypoxemia and bradycardia) may occur simultaneously or separately; their order of appearance is unpredictable 7, 10, 11, 22 and most terminate spontaneously. 7 Approximately 70% of the breath-holding episodes are 'central' in origin, about 10% are 'obstructive' and 30% are combined. 7 Most episodes appear within the first few hours following surgery. The first episode usually arises within the first 12 postoperative hours but may appear later. 1, 7, 15 Therefore, premature and formerpremature infants are closely monitored postoperatively and only if 'apnea-free' for 12-24 hr, are they transferred to a step-down unit.
The incidence of 'postoperative apnea' was 9.1% (five of 55). Higher 1 0 and lower 8, 17, 22 rates of 'postoperative apnea' have been reported previously following SA. A higher rate of postoperative apnea may have been demonstrated had we analyzed monitor-tracing recordings 7 , 8 or used nasal airflow thermistors. 10, 11 Nevertheless, this incidence may be related to the state of prematurity rather than to SA or surgery, since the incidence of pre-operative hypoxemia and apnea in this patient population is 33% and 17-28%, respectively. 1 0 Aseptic meningitis, a rare complication of SA, 2 6 was not observed in our study. The incidence of postdural puncture headache in infants is unknown, possibly due to their inability to verbalize pain, their natural horizontal position and a lack of documentation. 1 5 It may be argued that the combined dose of local anesthetics for SA (1 mg·kg -1 ) and for ilioinguinaliliohypogastric nerve block (2 mg·kg -1 ) may be too high for young infants because of concerns of local anesthetic toxicity. However, the first dose was administered before the beginning of surgery and the second at its end. Moreover, systemic absorption of bupivacaine after peripheral nerve or field block is slow while that after SA is quick in young infants. 15, 17 Therefore, we assumed that our patients would not be put under such a risk. In fact, no case of local anesthetic toxicity was observed in any of our patients.
Finally, application of EMLA® cream in infants younger than three months has been questioned because of concerns of methemoglobinemia. Single applications have not been shown to cause clinically significant methemoglobinemia in pre-term or fullterm neonates. [27] [28] [29] This may be due to the use of small doses 28,29 short duration of application 2 8 and absence of other risk factors (e.g., first few days of life in patients less than 32 weeks of gestational age, anemia and the concomitant administration of paracetamol) for methemoglobinemia. 28, 29 While paracetamol administration and anemia were common in our patients, clinical signs of methemoglobinemia were not observed (methemoglobin levels were not measured). However, our youngest patient was 36 weeks postconceptional age and only single small doses of EMLA® were applied. Although methemoglobin levels were not measured in this study, in no case were clinical signs of methemoglobinemia present.
In conclusion, SA for premature and former-premature infants, who have co-existing disease and risk factors for postoperative apnea, is an effective, easy and safe technique. Careful perioperative monitoring, a relatively high dose of hyperbaric local anesthetic solution with adrenaline, and appropriate patient positioning during LP and immediately following injection of the drug are important for the safe conduct of SA in young infants.
